Case Report: A Novel de novo Mutation in DNM1L Presenting With Developmental Delay, Ataxia, and Peripheral Neuropathy
1Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
A novel mutation in the DNM1L gene was identified in a child with developmental delay and ataxia. This finding expands the known spectrum of DNM1L-related neurological disorders.
Area of Science:
- Genetics
- Neuroscience
- Cell Biology
Background:
- The DNM1L gene encodes dynamin-related protein 1 (Drp1), crucial for mitochondrial and peroxisomal fission.
- De novo heterozygous missense mutations in DNM1L are associated with severe neurological conditions like epilepsy and brain atrophy.
Abstract:
DNM1L encodes dynamin-related protein 1 (Drp1), which is a member of the dynamin superfamily of GTPases and mediates mitochondrial and peroxisomal fission. In humans, several de novo heterozygous missense mutations in DNM1L have been reported, which were characterized by devastating courses with refractory epilepsy, myoclonus, and brain atrophy on MRI. We describe a 4.5-year-old male child harboring a novel de novo mutation in DNM1L presenting a phenotype of developmental delay, ataxia, and peripheral neuropathy. The clinical features, magnetic resonance imaging findings, and genetic results were summarized. Meanwhile, all the cases of DNM1L mutations reported were reviewed. DNM1L variants may need to be considered in phenotypes that include global developmental delay, peripheral neuropathy, and ataxia.
More Related Videos
Related Concept Videos
Animal Mitochondrial Genetics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...


